<PAGE>
OMB APPROVAL
OMB Number: 3235-0145
Expires: October 31, 1994
Estimated average burden
hours per response..14.90
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. __)*
Genovese Drug Stores, Inc.
(Name of Issuer)
Class A Common Stock, par value $1.00 per share
(Title of Class of Securities)
372442202
(CUSIP Number)
Check the following box if a fee is being paid with this
statement [X]. (A fee is not required only if the filing person:
(1) has a previous statement on file reporting beneficial
ownership of more than five percent of the class of securities
described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of
such class.) (See Rule 13d-7).
* The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect
to the subject class of securities, and for any subsequent
amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section
18 of the Securities Exchange Act of 1934 ("Act") or
otherwise subject to the liabilities of that section of the
Act but shall be subject to all other provisions of the Act
(however, see the Notes).
<PAGE>
<PAGE>
Page 2 of 8 Pages
CUSIP No. 372442202 13G
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Donald W. Gross
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
NUMBER OF 5 SOLE VOTING POWER
SHARES 0
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY 333,301
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 0
PERSON WITH 8 SHARED DISPOSITIVE POWER
333,301
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
333,301 (see Annex A)
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES
CERTAIN SHARES*
[ ]
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.1%
12 TYPE OF REPORTING PERSON*
IN
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
<PAGE>
Page 3 of 8 Pages
CUSIP No. 372442202 13G
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Marie A. Gross
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
NUMBER OF 5 SOLE VOTING POWER
SHARES 0
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY 333,301
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 0
PERSON WITH 8 SHARED DISPOSITIVE POWER
333,301
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
333,301 (see Annex A)
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES
CERTAIN SHARES*
[ ]
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.1%
12 TYPE OF REPORTING PERSON*
IN
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
<PAGE>
Page 4 of 8 Pages
Item 1(a). Name of Issuer:
Genovese Drug Stores, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
80 Marcus Drive
Melville, NY 11747
Item 2(a). Name of Person Filing:
Donald W. Gross and Marie A. Gross
Item 2(b). Address of Principal Business Office or, if None,
Residence:
80 Marcus Drive
Melville, NY 11747
Item 2(c). Citizenship:
United States of America
Item 2(d). Title of Class of Securities:
Class A Common Stock, par value $1.00 per share
Item 2(e). CUSIP Number:
372442202
Item 3. If this statement is filed pursuant to Rule 13d-
1(b), or 13d-2(b), check whether the person filing
is a:
Not applicable
Item 4. Ownership
(a) Amount Beneficially Owned
333,301 (see Annex A)
(b) Percent of Class
7.1%
(c) Number of shares as to which such persons
have:
(i) sole power to vote or to direct the vote
0
<PAGE>
Page 5 of 8 Pages
(ii) shared power to vote or to direct the
vote
333,301
(iii) sole power to dispose or to direct the
disposition of
0
(iv) shared power to dispose or to direct the
disposition of
333,301
Item 5. Ownership of Five Percent or Less of a Class
Not applicable
Item 6. Ownership of More than Five Percent on Behalf of
another Person
Not applicable
Item 7. Identification and Classification of the
Subsidiary Which Acquired the Security Being
Reported on By the Parent Holding Company
Not applicable
Item 8. Identification and Classification of Members of
the Group
Not applicable
Item 9. Notice of Dissolution of Group
Not applicable
Item 10. Certification
Not applicable
<PAGE>
<PAGE>
Page 6 of 8 Pages
SIGNATURE
After reasonable inquiry to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.
February 14, 1994
Date
/s/ Donald W. Gross
Donald W. Gross
/s/ Marie A. Gross
Marie A. Gross
<PAGE>
<PAGE>
Page 7 of 8 Pages
ANNEX A TO SCHEDULE 13G OF DONALD W. GROSS AND MARIE A. GROSS
The aggregate number of shares shown as beneficially owned by the
Reporting Persons includes the effect of a 10% stock dividend
paid in January 1994.
Of the aggregate number of shares shown as beneficially owned by
the Reporting Persons, 300,846 are beneficially owned in the form
of the Issuer's Class B Common Stock, par value $1.00 per share,
which class is not registered as a class of equity securities
under the Securities Exchange Act of 1934 but which can be
converted within 60 days into an equal number of shares of the
Issuer's Class A Common Stock.
<PAGE>
<PAGE>
Page 8 of 8 Pages
INDEX TO EXHIBITS
Exhibit No. Page
99.1* Agreement to Joint Filing
*Filed as Exhibit 99 pursuant to EDGAR rules.
<PAGE>
Exhibit 99.1
Agreement to Joint Filing
The undersigned persons hereby agree pursuant to Rule
13d-1(f) under the Securities Exchange Act of 1934, as amended,
that the Schedule 13G relating to the Class A Common Stock, par
value $1.00 per share, of Genovese Drug Stores, Inc. to which
this Agreement is attached is filed on behalf of each of them.
IN WITNESS WHEREOF, the undersigned have duly signed
this Agreement this 14th day of February, 1994.
/s/Donald W. Gross
Donald W. Gross
/s/Marie A. Gross
Marie A. Gross
